[
  {
    "ACR": "American College of Rheumatology"
  },
  {
    "EULAR": "European League Against Rheumatism"
  },
  {
    "AD": "Autoimmune Disease"
  },
  {
    "AE": "Adverse Event"
  },
  {
    "AHSCT": "Autologous Hematopoietic Stem Cell Transplantation"
  },
  {
    "BMI": "Body Mass Index"
  },
  {
    "CTC-AE": "NCI Common Terminology Criteria for Adverse Events"
  },
  {
    "CRISS": "ACR Provisional Composite Response Index for Clinical Trials in Early Diffuse Cutaneous Systemic Sclerosis"
  },
  {
    "DLCO": "diffusing capacity of lung for carbon monoxide"
  },
  {
    "EQ-5D-5L": "EuroQol 5-Dimension 5-Level"
  },
  {
    "FVC": "Forced Vital Capacity"
  },
  {
    "GMP": "Good Manufacturing Practices"
  },
  {
    "GRCS": "Global Rank Composite Score"
  },
  {
    "HRQoL": "Health-Related Quality of Life"
  },
  {
    "IV": "Intraveinous"
  },
  {
    "MMF": "Mycophenolate mofetil"
  },
  {
    "mRSS": "modified Rodnan Skin Score"
  },
  {
    "MSC": "Mesenchymal Stromal Cells"
  },
  {
    "MSC (AT)": "Mesenchymal Stromal Cells derived from AdiposeTissue"
  },
  {
    "MSC (M)": "Mesenchymal Stromal Cells derived from bone Marrow"
  },
  {
    "MSC (UC)": "Marrow derived Mesenchymal Stromal Cells derived from Umbilical Cord"
  },
  {
    "QALY": "Quality-Adjusted Life Year"
  },
  {
    "PFS": "Progression-Free Survival"
  },
  {
    "SAE": "Severe Adverse Event"
  },
  {
    "SAR": "Serious Adverse Reactions"
  },
  {
    "SHAQ": "Scleroderma-Health Assessment Questionnaire"
  },
  {
    "SF-36": "The Short Form (36) Health Survey"
  },
  {
    "SSc": "Systemic Sclerosis"
  }
]